Form CORRESP - Correspondence:
SEC Accession No. 0001193125-24-021092
Filing Date
2024-01-31
Accepted
2024-01-31 17:22:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 6497
  Complete submission text file 0001193125-24-021092.txt   7472
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)